Investor FAQ

1.When was Edge founded?
 Edge Therapeutics was founded in 2009.
2.Where is Edge Therapeutics’ corporate headquarters?
  Edge Therapeutics, Inc. is headquartered at 300 Connell Drive Suite 4000, Berkeley Heights, NJ 07922.
3.When did Edge Therapeutics go public?
 October 1, 2015
4.Where is the stock traded?
 The stock is traded on the Nasdaq Global Select Market under the ticker symbol “EDGE”.
5.What exchange are you listed on?
6.Who is Edge’s transfer agent?
 Computershare Investor Services 781-575-4238 (outside U.S.)
877-373-6374 (inside U.S.)

P.O. Box 43023
Providence, RI 02940
7.Does Edge have a direct stock purchase plan?
 No, Edge Therapeutics does not have a direct stock purchase plan. Shares may be purchased through a broker of your choice.
8.Whom shall I contact if I have further questions?
 Please contact Investor Relations at

Printer Friendly Version Print PageE-mail this page Email PageRSS RSS FeedsE-mail Alerts Email AlertsView contacts IR Contacts